Bipartisan PBM Reforms Mark Progress Toward Lower Drug Costs for Patients
Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829
Washington, DC – Today, the National Consumers League applauds the passage of the bipartisan Consolidated Appropriations Act of 2026 (CAA), which includes meaningful reforms to hold pharmacy benefit managers (PBMs) accountable and bring greater transparency to the prescription drug marketplace. These reforms are an important step toward ensuring that patients, employers, and plan sponsors benefit from lower drug costs—not entities who profit from opaque pricing practices.
“PBMs often work behind closed doors, raising costs for patients while diverting savings from those who need them most,” said Sally Greenberg, CEO of the National Consumers League. “By increasing transparency and prioritizing patients Congress has taken a positive step toward a fairer, more accountable prescription drug marketplace.”
###
About the National Consumers League (NCL)
The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.









